Connect with us

Latest News

Experimental Alzheimer’s drug 35% more effective than placebo: Eli Lilly

Published

on

Over an 18-month trial, people with early-stage Alzheimer’s who received donanemab showed 35% less decline in thinking skills. Read More

Continue Reading
Comments